US Stock MarketDetailed Quotes

CVGW Calavo Growers

Watchlist
  • 23.410
  • -0.190-0.81%
Close Mar 10 16:00 ET
  • 23.410
  • 0.0000.00%
Post 16:20 ET
417.57MMarket Cap-390.17P/E (TTM)

Calavo Growers Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Calavo Growers Q1 2025 Estimates Date

Currency：USDMar 12, 2025

Estimate YoY
Revenue
161.55M
+26.60%
EPS
0.29
+182.88%
Analyst Rating
Buy

Feb 28, 2025

Calavo Growers Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 192.750M--
Mar 12, 20252025/Q1-- / 161.550M--
--2024/Q4169.959M / 161.933M--
Sep 9, 20242024/Q3179.596M / 178.567M--
Jun 10, 20242024/Q2184.383M / 165.825M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 192.750M--
Mar 12, 20252025/Q1-- / 161.550M--
--2024/Q4169.959M / 161.933M--
Sep 9, 20242024/Q3179.596M / 178.567M--
Jun 10, 20242024/Q2184.383M / 165.825M--

Unlock Free Earnings Estimates

Calavo Growers Earnings Reports

  • Calavo Growers | 8-K: Calavo Growers, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results

    Jan 21 12:29 ET

  • Calavo Growers | 10-K: FY2024 Annual Report

    Jan 14 17:23 ET

  • Calavo Growers | 10-K/A: Annual report (Amendment)

    Dec 13, 2024 17:22 ET

  • Calavo Growers | 10-Q: Q3 2024 Earnings Report

    Sep 9, 2024 17:01 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +3.45%
    Collegium Pharmaceutical
    COLL
    +2.59%
    Constellation Brands
    STZ
    +1.73%
    Halozyme Therapeutics
    HALO
    +0.75%
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data